Coya Therapeutics (COYA) Current Assets (2021 - 2026)

Coya Therapeutics (COYA) has 6 years of Current Assets data on file, last reported at $53.3 million in Q1 2026.

• For the quarter ending Q1 2026, Current Assets rose 38.8% year-over-year to $53.3 million; the trailing twelve-month figure through Mar 2026 stood at $53.3 million (up 38.8% YoY), and the FY2025 full-year result was $49.9 million, up 12.71% from the prior year.
• Current Assets rose to $53.3 million in Q1 2026, from $49.9 million in the prior quarter.
• In the past five years, Current Assets ranged from a high of $53.3 million in Q1 2026 to a low of $7.2 million in Q4 2022.
• A 5-year average of $32.6 million and a median of $36.4 million in 2024 frame the typical range for Current Assets.
• Across the five-year window, Current Assets surged 473.37% in 2023 and declined 16.19% in 2025, its largest moves.
• Tracing COYA's Current Assets over 5 years: stood at $7.2 million in 2022, then surged by 473.37% to $41.2 million in 2023, then grew by 7.55% to $44.3 million in 2024, then climbed by 12.71% to $49.9 million in 2025, then increased by 6.66% to $53.3 million in 2026.
• Business Quant data shows COYA's Current Assets at $53.3 million in Q1 2026, $49.9 million in Q4 2025, and $32.0 million in Q3 2025.